Volume 65, Issue 1, Pages S82-S94 (October 2016)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 61, Issue 2, Pages (August 2014)

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

The impact of hepatitis E in the liver transplant setting

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Volume 50, Issue 4, Pages (April 2009)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Volume 65, Issue 5, Pages (November 2016)

Extrahepatic Manifestations of HCV Infection

Volume 68, Issue 5, Pages (May 2018)

Volume 42, Issue 6, Pages (June 2005)

Primary prevention of variceal haemorrhage: A pharmacological approach

Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou

Volume 61, Issue 6, Pages (December 2014)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

The impact of hepatitis E in the liver transplant setting

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Volume 42, Issue 1, Pages (January 2005)

NS5A inhibitors in the treatment of hepatitis C

Volume 65, Issue 1, Pages S82-S94 (October 2016)

Immigration and viral hepatitis

Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis Astrid Marot, Jean Henrion, Jean-François.

Virological tools to diagnose and monitor hepatitis C virus infection

Living donor liver transplantation: is the hype over?

Thomas F. Baumert, Catherine Fauvelle, Diana Y. Chen, Georg M. Lauer

David G. Bowen, Christopher M. Walker Journal of Hepatology

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection Anaïs Vallet-Pichard,

Chronic HCV infection and the clonality of intrahepatic T cells

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Hepatitis C and Lymphoproliferative Disorders: From Mixed Cryoglobulinemia to Non- Hodgkin's Lymphoma Lenna A. Martyak, Melina Yeganeh, Sammy Saab Clinical.

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study.

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 54, Issue 5, Pages (May 2011)

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Genomic risk of hepatitis C-related hepatocellular carcinoma

Darius Moradpour, Arash Grakoui, Michael P. Manns

Autophagy in the liver Journal of Hepatology

Volume 59, Issue 3, Pages (September 2013)

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Volume 61, Issue 1, Pages S45-S57 (November 2014)

Age and liver transplantation

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Immigration and viral hepatitis

HCV targeting of patients with cirrhosis

Volume 63, Issue 1, Pages (July 2015)

Volume 51, Issue 2, Pages (August 2009)

Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences Zobair M. Younossi, Aybike Birerdinc,

Chronic hepatitis B in children and adolescents

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Volume 54, Issue 6, Pages (June 2011)

Supportive care for patients with renal disease: Time for action

Hepatitis E virus: Infection beyond the liver?

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Volume 65, Issue 1, Pages S82-S94 (October 2016) Hepatitis C virus infection and chronic kidney disease: Time for reappraisal Patrice Cacoub, Anne Claire Desbois, Corinne Isnard-Bagnis, Dario Rocatello, Clodoveo Ferri Journal of Hepatology Volume 65, Issue 1, Pages S82-S94 (October 2016) DOI: 10.1016/j.jhep.2016.06.011 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 In addition to the primary manifestation of HCV in the liver, many extrahepatic manifestations have been reported to be associated to chronic HCV infection. These include cardiovascular diseases, type 2 diabetes and insulin resistance, neurocognitive dysfunction, systemic vasculitis, B cell non-Hodgkin lymphoma and chronic kidney disease. Patients chronically infected by HCV present a high risk of chronic renal impairment and have a linked, increase in morbidity and mortality. Journal of Hepatology 2016 65, S82-S94DOI: (10.1016/j.jhep.2016.06.011) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions